Back to results
US 12,590,170 B2Granted
Recombinant human antibodies that inhibit the human tissue kallikrein 7 (KLK7) and their use against diseases that cause desquamation of the skin
AssigneesFundação Universidade Federal do ABC - UFABC, Technische Universität Braunschweig
InventorsLuciano Puzer, Ana Flávia Santarine Laureano, Daniele Ribeiro De Araújo, Michael Hust
Life of this patent
Estimating the term…
Abstract
The present invention relates to human tissue kallikrein 7 (KLK7) selective inhibitor compounds, combinations including these compounds, process to obtain the referred compounds, and methods of using the same. The present invention belongs to the field of chemistry, pharmacology and medicine.
Claims15
An antibody, or a fragment thereof, wherein the antibody comprises the amino acids sequence of any one of SEQ ID NO:
- 18, 20, 22, 24 or 26.
Dependencies are inferred from the claim text.